1. Home
  2. SNTI vs CNVS Comparison

SNTI vs CNVS Comparison

Compare SNTI & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$0.97

Market Cap

22.8M

Sector

Health Care

ML Signal

HOLD

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$3.08

Market Cap

60.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNTI
CNVS
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
22.8M
60.1M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
SNTI
CNVS
Price
$0.97
$3.08
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$9.00
$9.00
AVG Volume (30 Days)
164.0K
436.5K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.99
EPS
N/A
N/A
Revenue
N/A
$78,181,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$150.00
$30.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.13
52 Week Low
$0.80
$1.77
52 Week High
$5.10
$7.39

Technical Indicators

Market Signals
Indicator
SNTI
CNVS
Relative Strength Index (RSI) 48.82 67.66
Support Level $0.80 $2.47
Resistance Level $1.19 $3.49
Average True Range (ATR) 0.07 0.27
MACD 0.02 0.08
Stochastic Oscillator 72.05 75.99

Price Performance

Historical Comparison
SNTI
CNVS

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

Share on Social Networks: